Study: Non-epileptic seizures marked by protein; Protagen, MicroDiscovery to collaborate on new biomarkers;

> New research from Rhode Island Hospital found that reduced levels of brain-derived neurotrophic factor, a protein in the brain that encourages growth of neurons, may be a trait marker for individuals with psychogenic non-epileptic seizures (seizures that are psychological in origin). The findings are published in the October 4, 2010, issue of Neurology, the medical journal of the American Academy of Neurology. Release

> Protagen AG and MicroDiscovery GmbH have inked a deal to collaborate on the development of new biomarkers for disease. Protagen release

> Canary Foundation researchers at Stanford University received the National Cancer Institute Early Detection Research Network Biomarker Development Laboratory Grant. This award came at the same time as the FDA approved an eIND for Canary Foundation research in the testing of molecular imaging agents for lung cancer. Canary Foundation release

> Predictive Biomarker Sciences says that it has inked deals with three developers to illuminate the mechanisms of action of their experimental therapies. PBS-Bio release

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.